Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phenotypes of complement knockouts.

V M Holers1

  • 1Division of Rheumatology, Box B-115, University of Colorado Health Sciences Center, Denver 80262, USA. michael.holers@uchsc.edu

Immunopharmacology
|July 25, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protein arginine deiminase 4 inhibition is sufficient for the amelioration of collagen-induced arthritis.

Clinical and experimental immunology·2017
Same author

Human C3b- and C4b-regulatory proteins: a new multi-gene family.

Immunology today·2014
Same author

Smoking is not associated with autoantibody production in systemic lupus erythematosus patients, unaffected first-degree relatives, nor healthy controls.

Lupus·2014
Same author

Complement activation and mortality during an acute episode of thrombotic thrombocytopenic purpura.

Journal of thrombosis and haemostasis : JTH·2013
Same author

Studies of Filipino patients with systemic lupus erythematosus: autoantibody profile of first-degree relatives.

Lupus·2010
Same author

Supervised machine learning and logistic regression identifies novel epistatic risk factors with PTPN22 for rheumatoid arthritis.

Genes and immunity·2010
Same journal

Papers of the 15th International Conference on Kinins. Part III. Nara, Japan, 19-24 October 1998.

Immunopharmacology·2001
Same journal

Papers from the 15th International Conference on Kinins. Part II. Nara, Japan, 19-24 October 1998.

Immunopharmacology·2001
Same journal

Interleukin 2 maintains biologic stability and sterility over prolonged time.

Immunopharmacology·2000
Same journal

Comparative study of lymphocyte-suppressive potency between prednisolone and methylprednisolone in rheumatoid arthritis.

Immunopharmacology·2000
Same journal

Activation of rat splenic macrophage and lymphocyte functions by fumonisin B1.

Immunopharmacology·2000
Same journal

Sublytic complement attack reduces infarct size in rabbit isolated hearts: evidence for C5a-mediated cardioprotection.

Immunopharmacology·2000
See all related articles

Engineered mice with targeted complement deficiencies offer new insights into human immune responses. These models are crucial for understanding the precise roles of complement proteins and their impact on clinical conditions.

Area of Science:

  • Immunology
  • Genetics
  • Animal Models

Background:

  • Complement deficiencies in humans and spontaneous models present research limitations.
  • Understanding the exact role of complement deficiencies in clinical manifestations remains challenging.
  • Mechanistic questions are difficult to address using patients or spontaneous animal models.

Purpose of the Study:

  • To provide insights into complement deficiency states.
  • To create readily manipulable experimental systems for studying complement.
  • To review complement-deficient mouse models and their findings.

Main Methods:

  • Targeted insertional mutagenesis in mice to create complete deficiencies.
  • Development of mouse models for complement activation proteins, receptors, and regulatory proteins.

Related Experiment Videos

  • Review of existing literature and findings from these engineered mouse models.

    • Main Results:

    • Engineered mice with complement deficiencies have been successfully created.
    • Surprising findings have emerged from studies using these targeted mouse models.
    • Clinically relevant studies are providing significant insights into human complement deficiency states.

    Conclusions:

    • Complement-deficient mice are valuable tools for immunological research.
    • These models facilitate a deeper understanding of complement's role in health and disease.
    • Future research directions using these models are critical for advancing the field.